CVT500 (Ranexa 500 mg)

Generic Name: ranolazine

Pill imprint CVT500 has been identified as Ranexa 500 mg.

Ranexa is used in the treatment of angina and belongs to the drug class antianginal agents. Risk cannot be ruled out during pregnancy. Ranexa 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for CVT500

Ranexa 500 mg CVT500
Ranexa
Generic Name:
ranolazine
Imprint:
CVT500
Strength:
500 mg
Color:
Orange
Size:
17.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antianginal agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
CV Therapeutics, Inc
National Drug Code (NDC):
67159-0112
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
61958-1001 Gilead Sciences, Inc.

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)